Related Experiment Video
Updated: Jul 13, 2026
11:59
Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids
Published on: May 15, 2019
Antibacterial targets in fatty acid biosynthesis
H Tonie Wright1, Kevin A Reynolds
1Department of Biochemistry and Institute of Structural Biology and Drug Discovery, Virginia Commonwealth University, 800 E. Leigh St. Suite 212, Richmond, VA 23219-1540, USA. reynoldsk@pdx.edu
Current Opinion in Microbiology
|August 21, 2007
Summary
Fatty acid biosynthesis is a promising target for new antibacterial drugs. Novel natural products and structural data enable the rational design of specific inhibitors for combating bacterial infections.
Area of Science:
- Microbiology
- Medicinal Chemistry
- Biochemistry
Background:
- The fatty acid biosynthesis pathway is a validated target for antibacterial agents, with existing drugs like isoniazid and triclosan demonstrating its potential.
- Differences in fatty acid synthase systems between bacteria and eukaryotes offer opportunities for developing host-specific inhibitors.
- Recent discoveries of natural product inhibitors and structural data provide new avenues for drug development.
Purpose of the Study:
- To highlight the potential of the fatty acid biosynthesis pathway as a target for novel antibacterial agents.
- To discuss the significance of structural information in the rational design of inhibitors.
- To introduce new classes of natural product inhibitors with antibiotic potential.
Main Methods:
- Review of existing literature on fatty acid biosynthesis inhibitors and their mechanisms of action.
- Analysis of structural data for type I and type II fatty acid synthase systems.
- Characterization of newly discovered natural product inhibitors like platensimycin, platencin, and phomallenic acids.
Main Results:
- Fatty acid biosynthesis inhibitors like isoniazid and triclosan are effective antibacterial agents.
- Platensimycin, platencin, and phomallenic acids represent new classes of compounds inhibiting fatty acid biosynthesis.
- Extensive structural data for fatty acid synthase enzymes are available for rational drug design.
Conclusions:
- The fatty acid biosynthesis pathway remains a largely untapped resource for developing innovative antibacterial therapies.
- Structural insights into fatty acid synthase enzymes are crucial for designing targeted and specific inhibitors.
- New natural product-derived compounds show significant promise as future antibiotics.
Related Concept Videos
01:29Biosynthesis of Lipids
Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis pathway, which...
01:25Lipid Catabolism
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
01:24Biosynthesis in Bacteria
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...